NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 47 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,000 | -38.1% | 20,300 | 0.0% | 0.00% | – |
| Q2 2022 | $21,000 | -52.3% | 20,300 | -13.4% | 0.00% | – |
| Q1 2022 | $44,000 | -42.9% | 23,434 | +46.2% | 0.00% | – |
| Q4 2021 | $77,000 | -34.2% | 16,034 | -0.6% | 0.00% | – |
| Q3 2021 | $117,000 | -64.3% | 16,134 | -54.6% | 0.00% | – |
| Q2 2021 | $328,000 | -13.0% | 35,534 | +16.1% | 0.00% | – |
| Q1 2021 | $377,000 | +33.2% | 30,594 | +52.4% | 0.00% | – |
| Q4 2020 | $283,000 | +76.9% | 20,076 | +50.5% | 0.00% | – |
| Q3 2020 | $160,000 | -86.1% | 13,338 | -96.7% | 0.00% | – |
| Q3 2019 | $1,151,000 | – | 403,919 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,291,133 | $1,166,187 | 1.01% |
| Privium Fund Management (UK) Ltd | 117,200 | $59,655 | 0.04% |
| Redmile Group, LLC | 1,850,566 | $941,938 | 0.04% |
| Baker Brothers Advisors | 3,821,740 | $1,945,266 | 0.01% |
| Kynam Capital Management, LP | 120,764 | $61,469 | 0.01% |
| Sio Capital Management, LLC | 38,312 | $19,501 | 0.01% |
| SIMON QUICK ADVISORS, LLC | 46,856 | $23,850 | 0.00% |
| Tri Locum Partners LP | 10,248 | $5,000 | 0.00% |
| Endurance Wealth Management, Inc. | 20,000 | $10 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $38,175 | 0.00% |